Overview

  • Product nameAnti-GALNT7 antibody
    See all GALNT7 primary antibodies
  • Description
    Rabbit polyclonal to GALNT7
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat
  • Immunogen

    Recombinant fragment containing a sequence corresponding to a region within amino acids 24-485 of Human GALNT7 (NP_059119).

  • Positive control
    • A431 whole cell lysate; 293T, H1299, HeLaS3, HepG2, Molt-4 and Raji cell lysates

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferPreservative: 0.01% Thimerosal (merthiolate)
    Constituents: 10% Glycerol, 0.1M Tris, 0.1M Glycine, pH 7.0
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Associated products

Applications

Our Abpromise guarantee covers the use of ab97645 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500 - 1/3000. Predicted molecular weight: 75 kDa.

Target

  • FunctionGlycopeptide transferase involved in O-linked oligosaccharide biosynthesis, which catalyzes the transfer of an N-acetyl-D-galactosamine residue to an already glycosylated peptide. In contrast to other proteins of the family, it does not act as a peptide transferase that transfers GalNAc onto serine or threonine residue on the protein receptor, but instead requires the prior addition of a GalNAc on a peptide before adding additional GalNAc moieties. Some peptide transferase activity is however not excluded, considering that its appropriate peptide substrate may remain unidentified.
  • Tissue specificityWidely expressed. Expressed in uterus, retina, kidney, small intestine, omentum, stomach and CNS.
  • PathwayProtein modification; protein glycosylation.
  • Sequence similaritiesBelongs to the glycosyltransferase 2 family. GalNAc-T subfamily.
    Contains 1 ricin B-type lectin domain.
  • DomainThere are two conserved domains in the glycosyltransferase region: the N-terminal domain (domain A, also called GT1 motif), which is probably involved in manganese coordination and substrate binding and the C-terminal domain (domain B, also called Gal/GalNAc-T motif), which is probably involved in catalytic reaction and UDP-Gal binding.
    The ricin B-type lectin domain binds to GalNAc and contributes to the glycopeptide specificity.
  • Cellular localizationGolgi apparatus membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • GalNAc T7 antibody
    • GalNAc-T7 antibody
    • GalNAcT7 antibody
    • GALNT 7 antibody
    • Galnt7 antibody
    • GALT7_HUMAN antibody
    • N acetylgalactosaminyltransferase 7 antibody
    • N-acetylgalactosaminyltransferase 7 antibody
    • Polypeptide GalNAc transferase 7 antibody
    • Polypeptide N acetylgalactosaminyltransferase 7 antibody
    • pp GaNTase 7 antibody
    • pp-GaNTase 7 antibody
    • Protein UDP acetylgalactosaminyltransferase 7 antibody
    • Protein-UDP acetylgalactosaminyltransferase 7 antibody
    • UDP GalNAc:polypeptide N acetylgalactosaminyltransferase 7 antibody
    • UDP N acetyl alpha D galactosamine:polypeptide N acetylgalactosaminyltransferase 7 antibody
    • UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7 antibody
    see all

Anti-GALNT7 antibody images

  • Anti-GALNT7 antibody (ab97645) at 1/10000 dilution + A431 whole cell lysate at 30 µg

    Predicted band size : 75 kDa

References for Anti-GALNT7 antibody (ab97645)

ab97645 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab97645.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"